BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28523396)

  • 21. Protein- and DNA-based anthrax toxin vaccines confer protection in guinea pigs against inhalational challenge with Bacillus cereus G9241.
    Palmer J; Bell M; Darko C; Barnewall R; Keane-Myers A
    Pathog Dis; 2014 Nov; 72(2):138-42. PubMed ID: 25044336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile.
    Zhang BZ; Cai J; Yu B; Hua Y; Lau CC; Kao RY; Sze KH; Yuen KY; Huang JD
    BMC Infect Dis; 2016 Oct; 16(1):596. PubMed ID: 27770789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
    Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
    Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization of mice against alpha, beta, and epsilon toxins of Clostridium perfringens using recombinant rCpa-b-x expressed by Bacillus subtilis.
    Wang Y; Miao Y; Hu LP; Kai W; Zhu R
    Mol Immunol; 2020 Jul; 123():88-96. PubMed ID: 32447084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and characterization of recombinant bivalent fusion protein r-Cpib for immunotherapy against Clostridium perfringens beta and iota toxemia.
    Das S; Majumder S; Kingston JJ; Batra HV
    Mol Immunol; 2016 Feb; 70():140-8. PubMed ID: 26774054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with Clostridium perfringens recombinant proteins in combination with Montanide™ ISA 71 VG adjuvant increases protection against experimental necrotic enteritis in commercial broiler chickens.
    Jang SI; Lillehoj HS; Lee SH; Lee KW; Lillehoj EP; Hong YH; An DJ; Jeong W; Chun JE; Bertrand F; Dupuis L; Deville S; Arous JB
    Vaccine; 2012 Aug; 30(36):5401-6. PubMed ID: 22713719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium perfringens alpha-toxin and NetB toxin antibodies and their possible role in protection against necrotic enteritis and gangrenous dermatitis in broiler chickens.
    Lee KW; Lillehoj HS; Park MS; Jang SI; Ritter GD; Hong YH; Jeong W; Jeoung HY; An DJ; Lillehoj EP
    Avian Dis; 2012 Mar; 56(1):230-3. PubMed ID: 22545552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
    Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y
    Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis.
    Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
    Vet Res; 2016 Apr; 47(1):52. PubMed ID: 27121298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
    Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.
    Schoepe H; Pache C; Neubauer A; Potschka H; Schlapp T; Wieler LH; Baljer G
    Infect Immun; 2001 Nov; 69(11):7194-6. PubMed ID: 11598102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral immunization of mice against Clostridium perfringens epsilon toxin with a Lactobacillus casei vector vaccine expressing epsilon toxoid.
    Alimolaei M; Golchin M; Daneshvar H
    Infect Genet Evol; 2016 Jun; 40():282-287. PubMed ID: 27012151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological and immunological studies on toxoids vaccine as a successful alternative in controlling clostridial infection in broilers.
    Saleh N; Fathalla SI; Nabil R; Mosaad AA
    Anaerobe; 2011 Dec; 17(6):426-30. PubMed ID: 21664285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of rabbits with recombinant Clostridium perfringens alpha toxins CPA-C and CTB-CPA-C in a bicistronic design expression system confers strong protection against challenge.
    Peng X; Peng G; Li X; Feng L; Dong L; Jiang Y
    Protein Expr Purif; 2020 Mar; 167():105550. PubMed ID: 31811913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with a novel Clostridium perfringens epsilon toxin mutant rETX(Y196E)-C confers strong protection in mice.
    Yao W; Kang J; Kang L; Gao S; Yang H; Ji B; Li P; Liu J; Xin W; Wang J
    Sci Rep; 2016 Apr; 6():24162. PubMed ID: 27048879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization of sheep with a recombinant vaccine containing immunogenic nontoxic domains of Clostridium perfringens alpha and beta toxins.
    Rodrigues Rodrigues R; Freitas Motta J; Alves Ferreira MR; Moreira Júnior C; Ferreira Alves ML; Costa AV; Andrade Bilhalva M; Amaral Donassolo R; Cancela Galvão C; Silva Martins FM; Masiero Salvarani F; Rochedo Conceição F
    Microb Pathog; 2023 Sep; 182():106269. PubMed ID: 37516212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA vaccination with map1 gene followed by protein boost augments protection against challenge with Cowdria ruminantium, the agent of heartwater.
    Nyika A; Barbet AF; Burridge MJ; Mahan SM
    Vaccine; 2002 Jan; 20(7-8):1215-25. PubMed ID: 11803084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
    Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.